• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过 NKT-肝癌细胞相互作用,相互调节的 PD-1 和 PD-L1 表达影响杀伤效率。

Killing efficiency affected by mutually modulated PD-1 and PD-L1 expression via NKT-hepatoma cell interactions.

机构信息

School of Basic Medical Sciences, Anhui Medical University, No. 81 Meishan Road, Hefei City, Anhui Province, 230032, P.R. China.

Department of Hematology, The First Affiliated Hospital of Anhui Medical University, No. 218 Jixi Road, Hefei City, Anhui Province, 230000, China.

出版信息

Immunotherapy. 2021 Feb;13(2):113-123. doi: 10.2217/imt-2020-0062. Epub 2020 Oct 20.

DOI:10.2217/imt-2020-0062
PMID:33076728
Abstract

To explore the expression of programmed death-1 (PD-1) or programmed death ligand 1 (PD-L1), natural killer T (NKT) and hepatoma cells in coculture system, and the influence of abolishing PD-1 on antitumor efficiency. CRISPR/Cas9 technology, flow cytometry, ELISA, CCK-8 assay and mouse models were performed to investigate the interactions between PD-1/PD-L1 expression on NKT and hepatoma cells, respectively. The NKT and hepatoma cells mutually affected the expression of PD-1/PD-L1. The killing effect was positively correlated with NKT-mediated PD-L1 expression on hepatoma cells. Hepatoma cells in different genetic background responded differently to NKT-induced PD-L1 stimulation, and those cells with lower PD-L1 expression fail to PD-1 blocking intervention. Additionally, the killing effect was more time-efficient with PD-1 knockout than with monoclonal antibody blockade.

摘要

探讨共培养体系中程序性死亡受体 1(PD-1)或程序性死亡配体 1(PD-L1)、自然杀伤 T(NKT)细胞和肝癌细胞的表达,以及敲除 PD-1 对肿瘤杀伤效率的影响。采用 CRISPR/Cas9 技术、流式细胞术、ELISA、CCK-8 检测和小鼠模型,分别研究了 NKT 和肝癌细胞上 PD-1/PD-L1 表达之间的相互作用。NKT 和肝癌细胞相互影响 PD-1/PD-L1 的表达。杀伤效应与 NKT 介导的肝癌细胞上 PD-L1 的表达呈正相关。不同遗传背景的肝癌细胞对 NKT 诱导的 PD-L1 刺激的反应不同,表达 PD-L1 较低的细胞无法接受 PD-1 阻断干预。此外,与单克隆抗体阻断相比,PD-1 敲除的杀伤效果更具时效性。

相似文献

1
Killing efficiency affected by mutually modulated PD-1 and PD-L1 expression via NKT-hepatoma cell interactions.通过 NKT-肝癌细胞相互作用,相互调节的 PD-1 和 PD-L1 表达影响杀伤效率。
Immunotherapy. 2021 Feb;13(2):113-123. doi: 10.2217/imt-2020-0062. Epub 2020 Oct 20.
2
Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.SIRT7 缺失通过 MEF2D 调控程序性细胞死亡配体 1 增加肝癌细胞中检查点抑制剂的疗效。
Gastroenterology. 2020 Feb;158(3):664-678.e24. doi: 10.1053/j.gastro.2019.10.025. Epub 2019 Oct 31.
3
Programmed Death Ligand-1 (PD-L1) Regulated by NRF-2/MicroRNA-1 Regulatory Axis Enhances Drug Resistance and Promotes Tumorigenic Properties in Sorafenib-Resistant Hepatoma Cells.NRF-2/微小 RNA-1 调控轴调控的程序性死亡配体-1(PD-L1)增强索拉非尼耐药肝癌细胞的耐药性并促进其致瘤特性。
Oncol Res. 2020 Dec 10;28(5):467-481. doi: 10.3727/096504020X15925659763817. Epub 2020 Jun 19.
4
Lenvatinib Targets FGF Receptor 4 to Enhance Antitumor Immune Response of Anti-Programmed Cell Death-1 in HCC.乐伐替尼靶向成纤维细胞生长因子受体4以增强抗程序性细胞死亡蛋白1在肝癌中的抗肿瘤免疫反应。
Hepatology. 2021 Nov;74(5):2544-2560. doi: 10.1002/hep.31921. Epub 2021 Aug 25.
5
Pentamethylquercetin Inhibits Hepatocellular Carcinoma Progression and Adipocytes-induced PD-L1 Expression via IFN-γ Signaling.五甲基槲皮素通过 IFN-γ 信号抑制肝细胞癌进展和脂肪细胞诱导的 PD-L1 表达。
Curr Cancer Drug Targets. 2020;20(11):868-874. doi: 10.2174/1568009620999200730184514.
6
Programmed cell death protein-1 (PD-1)/programmed death-ligand-1 (PD-L1) axis in hepatocellular carcinoma: prognostic and therapeutic perspectives.肝细胞癌中的程序性细胞死亡蛋白 1(PD-1)/程序性死亡配体 1(PD-L1)轴:预后和治疗展望。
Clin Transl Oncol. 2019 Jun;21(6):702-712. doi: 10.1007/s12094-018-1975-4. Epub 2018 Nov 1.
7
α-Galactosylceramide but not phenyl-glycolipids induced NKT cell anergy and IL-33-mediated myeloid-derived suppressor cell accumulation via upregulation of egr2/3.α-半乳糖神经酰胺而非苯丙氨酸糖脂通过上调 egr2/3 诱导 NKT 细胞失能和 IL-33 介导的髓系来源抑制细胞积累。
J Immunol. 2014 Feb 15;192(4):1972-81. doi: 10.4049/jimmunol.1302623. Epub 2014 Jan 24.
8
Programmed Death Receptor 1 (PD1) Knockout and Human Telomerase Reverse Transcriptase (hTERT) Transduction Can Enhance Persistence and Antitumor Efficacy of Cytokine-Induced Killer Cells Against Hepatocellular Carcinoma.程序性死亡受体 1(PD1)敲除和人端粒酶逆转录酶(hTERT)转导可增强细胞因子诱导的杀伤细胞对肝癌的持久性和抗肿瘤疗效。
Med Sci Monit. 2018 Jul 3;24:4573-4582. doi: 10.12659/MSM.910903.
9
Development of canine PD-1/PD-L1 specific monoclonal antibodies and amplification of canine T cell function.犬 PD-1/PD-L1 特异性单克隆抗体的开发及犬 T 细胞功能的扩增。
PLoS One. 2020 Jul 2;15(7):e0235518. doi: 10.1371/journal.pone.0235518. eCollection 2020.
10
EZH2 negatively regulates PD-L1 expression in hepatocellular carcinoma.EZH2 负向调控肝细胞癌中 PD-L1 的表达。
J Immunother Cancer. 2019 Nov 14;7(1):300. doi: 10.1186/s40425-019-0784-9.

引用本文的文献

1
IL-2/GM-CSF enhances CXCR3 expression in CAR-T cells via the PI3K/AKT and ERK1/2 pathways.IL-2/GM-CSF 通过 PI3K/AKT 和 ERK1/2 通路增强 CAR-T 细胞中的 CXCR3 表达。
J Cancer Res Clin Oncol. 2023 Aug;149(9):5547-5557. doi: 10.1007/s00432-022-04509-w. Epub 2022 Dec 6.